Last updated at 22 Aug 2024 12:32 AM
Director
DIN: 07256786
Sanjay Jalona is currently associated with 2 companies as Director. They serve as a Director at GEBBS HEALTHCARE SOLUTIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07256786.Sanjay Jalona has previously been associated with 3 companies in roles such as Additional Director, Managing Director and Director.Sanjay Jalona is currently involved in 1 different role. Their most recent position is with XORIANT SOLUTIONS PRIVATE LIMITED as a Director. The first company Sanjay Jalona was appointed to as a director was GEBBS HEALTHCARE SOLUTIONS PRIVATE LIMITED. Sanjay Jalona is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sanjay Jalona is currently associated with 2 companies as Director. They serve as a Director at GEBBS HEALTHCARE SOLUTIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07256786.Sanjay Jalona has previously been associated with 3 companies in roles such as Additional Director, Managing Director and Director.Sanjay Jalona is currently involved in 1 different role. Their most recent position is with XORIANT SOLUTIONS PRIVATE LIMITED as a Director. The first company Sanjay Jalona was appointed to as a director was GEBBS HEALTHCARE SOLUTIONS PRIVATE LIMITED. Sanjay Jalona is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (3)
2y 1m 1y 1m Interval
Company Name | Designation | Date of Appointment |
---|---|---|
GEBBS HEALTHCARE SOLUTIONS PRIVATE LIMITED | Director | 28-Sep-2022 |
XORIANT SOLUTIONS PRIVATE LIMITED | Director | 30-Sep-2023 |